CurveBeam AIASX:CVB Days Payable is 112.31 as of Dec. 2025, which is 50% below its 10-year median of 225.64. The stock has 5 warning signs investors should review. Among 796 Medical Devices & Instruments companies, CurveBeam AI ranks better than 74.25% on this metric.
The historical rank and industry rank for CurveBeam AI's Days Payable or its related term are showing as below:
ASX:CVB'
s Days Payable Range Over the Past 10 Years
Min: 89.72 Med: 225.64 Max: 241.41
Current: 129.99
During the past 5 years, CurveBeam AI's highest Days Payable was 241.41. The lowest was 89.72. And the median was 225.64.
ASX:CVB's Days Payable is ranked better than 74.25% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs ASX:CVB: 129.99
CurveBeam AI's Days Payable
declined
from Dec. 2024 (188.63) to Dec. 2025 (112.31).
It may suggest that CurveBeam AIaccelerated paying its suppliers.
CurveBeam AI Days Payable Related Terms
CurveBeam AI Days Payable Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CurveBeam AI's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Days Payable distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
CurveBeam AI's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI (ASX:CVB) has a Days Payable of 112.31 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CurveBeam AI and its competitors. This is 50% below median its historical median of 225.64. Over the past decade, CurveBeam AI's Days Payable has ranged from 89.72 to 241.41. According to the industry distribution chart, CurveBeam AI ranks #205 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 25.8%.
Is CurveBeam AI's Days Payable too high?
CurveBeam AI's current Days Payable of 112.31 is 50% below median its 10-year median of 225.64. Over the past 10 years, this metric has ranged from a low of 89.72 to a high of 241.41. The Medical Devices & Instruments industry median Days Payable is 68.14. CurveBeam AI's value of 112.31 is 64.8% above this industry median. Based on the distribution chart, CurveBeam AI ranks #205 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does CurveBeam AI's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #205 out of 796 companies for Days Payable. This puts CurveBeam AI in the upper half of its industry. The industry median Days Payable is 68.14. CurveBeam AI's value of 112.31 is 64.8% above this benchmark. Historically, CurveBeam AI's own Days Payable has ranged from 89.72 to 241.41 over the past decade. While the company's 10-year median is 225.64 vs. the industry median of 68.14, CurveBeam AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CurveBeam AI's current Days Payable of 112.31 is 64.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on CurveBeam AI and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CurveBeam AI's current Days Payable is 112.31, which is 50% below median its own 10-year median of 225.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Days Payable of 112.31. The current Days Payable is 112.31, which is 50% below median its 10-year median of 225.64 and 64.8% above the Medical Devices & Instruments industry median of 68.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Days Payable is 112.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 